beryllium has been researched along with Autoimmune Diabetes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aittoniemi, J; Ashcroft, FM; de Wet, H; Ellard, S; Flanagan, SE; Hattersley, AT; Patch, AM; Rees, MG; Sansom, MS; Shimomura, K | 1 |
1 other study(ies) available for beryllium and Autoimmune Diabetes
Article | Year |
---|---|
Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amino Acid Substitution; Arginine; ATP-Binding Cassette Transporters; Beryllium; Binding Sites; Diabetes Mellitus, Type 1; Fluorides; Humans; Hydrolysis; Infant, Newborn; Insulin; Insulin Secretion; Ion Channel Gating; Kinetics; Models, Molecular; Mutation, Missense; Point Mutation; Potassium; Potassium Channels; Potassium Channels, Inwardly Rectifying; Protein Structure, Tertiary; Receptors, Drug; Structure-Activity Relationship; Sulfonylurea Receptors | 2007 |